Back

Identification of cellular senescence-related gene IFNG as a potential biomarker in acute rejection after kidney transplantation via weighted gene co-expression network analysis and multiple machine learning

Xu, C.; Wang, X.; Wu, H.; Li, W.; Lin, F.; Lin, N.; Shen, S.; Pan, S.; Chen, T.; Zhang, D.; He, L.; Cui, Y.

2025-06-20 nephrology
10.1101/2025.06.19.25329910 medRxiv
Show abstract

BackgroundKidney transplantation is the best option for the treatment of end-stage kidney disease (ESKD). Acute rejection (AR) episodes are a major determinant of renal allograft survival. Cellular senescence in the pathogenesis of allograft failure. Herein, we aimed to explore hub cellular senescence-related gene in AR after kidney transplantation. MethodsThe data used in this study was obtained from the Gene Expression Omnibus database. The hub cellular senescence-related gene was identified using WGCNA and three machine learning algorithms. The function information was analyzed using the GO and KEGG enrichment analysis. The correlation between hub gene and immune cells was calculated using ssGSEA algorithm and Pearsons correlation analysis. ResultsA total of 31 cellular senescence-related genes were differentially expressed in the AR and stable groups. Among which, 19 genes were correlated with onset of AR after kidney transplantation. After utilizing the three machine learning algorithms, IFNG was identified as the hub cellular senescence-related gene. IFNG was highly expressed in AR samples, and it could better distinguish between stable individuals and AR patients after kidney transplantation. Moreover, the expression of IFNG was closely correlated with immune cell infiltration and function. IFNG expression was associated with multiple drugs. Finally, we found that IFNG was high expressed in kidney tissues of AR in allogeneic kidney transplant mice ConclusionsOur study revealed that cellular senescence-related gene IFNG might be a potential biomarker AR after kidney transplantation.

Matching journals

The top 2 journals account for 50% of the predicted probability mass.

1
BioMed Research International
25 papers in training set
Top 0.1%
28.0%
2
PLOS ONE
4510 papers in training set
Top 4%
24.4%
50% of probability mass above
3
The FASEB Journal
175 papers in training set
Top 0.1%
4.3%
4
Scientific Reports
3102 papers in training set
Top 32%
3.9%
5
Journal of Clinical Medicine
91 papers in training set
Top 2%
3.1%
6
Frontiers in Cardiovascular Medicine
49 papers in training set
Top 1%
3.0%
7
Journal of Infection
71 papers in training set
Top 0.8%
2.2%
8
Kidney International Reports
14 papers in training set
Top 0.2%
2.0%
9
Journal of Molecular Cell Biology
21 papers in training set
Top 0.1%
2.0%
10
Frontiers in Pharmacology
100 papers in training set
Top 2%
1.8%
11
BMC Medicine
163 papers in training set
Top 3%
1.8%
12
Pathogens
53 papers in training set
Top 0.4%
1.8%
13
Health Science Reports
12 papers in training set
Top 0.1%
1.4%
14
BMC Nephrology
13 papers in training set
Top 0.2%
1.3%
15
Kidney360
22 papers in training set
Top 0.4%
1.2%
16
American Journal of Transplantation
15 papers in training set
Top 0.1%
0.9%
17
Transplantation
13 papers in training set
Top 0.4%
0.8%
18
Vaccines
196 papers in training set
Top 2%
0.8%
19
JAMA Network Open
127 papers in training set
Top 5%
0.7%
20
Journal of the American Society of Nephrology
52 papers in training set
Top 0.7%
0.5%
21
PLOS Genetics
756 papers in training set
Top 18%
0.5%
22
Frontiers in Medicine
113 papers in training set
Top 8%
0.5%